Free Trial

Cresco Labs Inc. (OTCMKTS:CRLBF) Receives Average Recommendation of "Buy" from Analysts

Cresco Labs logo with Medical background

Shares of Cresco Labs Inc. (OTCMKTS:CRLBF - Get Free Report) have earned an average rating of "Buy" from the four analysts that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and two have given a strong buy rating to the company.

Several equities research analysts recently commented on CRLBF shares. Canaccord Genuity Group downgraded Cresco Labs from a "strong-buy" rating to a "moderate buy" rating in a report on Tuesday, June 3rd. Cormark upgraded Cresco Labs from a "hold" rating to a "moderate buy" rating in a report on Monday, March 17th.

View Our Latest Analysis on CRLBF

Cresco Labs Stock Down 0.7%

Shares of CRLBF traded down $0.00 during trading hours on Friday, hitting $0.54. The company had a trading volume of 293,456 shares, compared to its average volume of 652,375. The firm has a fifty day moving average price of $0.68 and a 200-day moving average price of $0.82. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.39 and a current ratio of 1.97. The stock has a market capitalization of $263.48 million, a price-to-earnings ratio of -2.68 and a beta of 1.47. Cresco Labs has a 52-week low of $0.49 and a 52-week high of $2.05.

Cresco Labs (OTCMKTS:CRLBF - Get Free Report) last released its quarterly earnings data on Friday, May 30th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). Cresco Labs had a negative return on equity of 16.52% and a negative net margin of 9.15%. The business had revenue of $165.76 million during the quarter, compared to the consensus estimate of $164.37 million. On average, equities research analysts forecast that Cresco Labs will post -0.2 EPS for the current fiscal year.

About Cresco Labs

(Get Free Report

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Featured Stories

Should You Invest $1,000 in Cresco Labs Right Now?

Before you consider Cresco Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cresco Labs wasn't on the list.

While Cresco Labs currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Cheap Growth Stocks Set to Explode This Summer
The Next NVIDIA? Quantum Computing Stocks Set for Explosive Growth
5 Stocks to BUY NOW in July 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines